Actively Recruiting
Implementing Virtual Reality (VR) to Reduce Sedation
Led by NYU Langone Health · Updated on 2026-03-19
10
Participants Needed
1
Research Sites
90 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose of this study is to assess the feasibility, effect, and safety of using VR goggles during endoscopic procedures to decrease sedation requirements, enhance patient satisfaction, and reduce recovery time.
CONDITIONS
Official Title
Implementing Virtual Reality (VR) to Reduce Sedation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
- Aged 21 to 65
You will not qualify if you...
- Visual impairments such as blindness preventing use of VR goggles
- History of coronary artery disease (CAD)
- History of seizures
- History of vertigo
- Allergy to plastic
- ASA II or III classification
- Active gastrointestinal bleeding presenting as melena or hematochezia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Brooklyn
Brooklyn, New York, United States, 11220
Actively Recruiting
Research Team
M
Maysaa El Zoghbi, MD
CONTACT
G
Gregory Faulx
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here